Back to trial details

Intake questionnaire

A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)

Applying to Emory Winship Cancer Institute · Atlanta, Georgia

Answer a few short questions to share with the research team.

0 of 3 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Non-small Cell Lung Cancer (NSCLC)?
3. Are you able to travel to Atlanta for study visits?